BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

RheoGene, Inc. 

2650 Eisenhower Avenue

Norristown  Pennsylvania  19403  U.S.A.
Phone: 610-650-8734 Fax: 610-650-8755


SEARCH JOBS




Industry
Biotechnology

Segment
Genomics





 Company News
RheoGene, Inc. Merger With Intrexon Corporation Creates Biotech Firm Targeting Gene-Based Therapies 12/19/2006 1:58:17 PM
RheoGene, Inc. To Participate In CNS Focus Session At Eighth Annual Biotechnology Industry Organization (BIO) CEO And Investor Conference 2/13/2006 3:43:51 PM
RheoGene, Inc. Grants Ichor Medical Systems, Inc. A Commercial License To Develop A Regulated Gene Therapy For Multiple Sclerosis Using The RheoSwitch® Therapeutic System 2/9/2006 2:09:51 PM
CHEMICON International, Inc. (SERO) Enters Into License Agreement With RheoGene, Inc. 11/28/2005 1:19:36 PM
RheoGene, Inc. And TissueGene Inc. Sign Collaborative Agreement For Bone Regeneration And Repair10/19/2005 5:13:13 PM
RheoGene, Inc. And New England Biolabs, Inc. Sign Licensing Agreement For RheoSwitch(TM) Research Kits10/19/2005 5:11:43 PM
J. Mark Braughler Joins RheoGene, Inc. As Vice President Of Therapeutics10/19/2005 5:11:31 PM
RheoGene, Inc. Introduces AttSite(TM) Recombinases10/19/2005 5:10:20 PM
RheoGene, Inc. Grants Xenogen Corporation (XGEN) A License To Develop RheoMice™ Transgenics10/19/2005 5:09:20 PM
RheoGene, Inc. Adds Internationally Renowned Gene Therapy Experts To Its Scientific Advisory Board10/19/2005 5:09:04 PM
12